To test whether a large number of model antigen-reactive CD8+ T cells was sufficient to replicate the efficacy of RT in Panc02SIY100, we used a live-attenuated Listeria monocytogenes vaccine expressing SIY (LmSIY) to generate large numbers of tumor-reactive CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.